NovaBridge Biosciences (NBP) Inventory (2021 - 2023)

NovaBridge Biosciences (NBP) has 3 years of Inventory data on file, last reported at $718742.3 in Q4 2023.

• Inventory for Q4 2023 came in at $718742.3, down 84.49% year-over-year; the trailing twelve-month figure through Dec 2023 was $718742.3 (down 84.49% YoY), and the FY2023 annual result was $729000.0, down 84.75% from the prior year.
• Inventory fell to $718742.3 in Q4 2023 per NBP's latest filing, from $4.6 million in the prior quarter.
• Over five years, Inventory peaked at $4.3 billion in Q4 2021 and troughed at $718742.3 in Q4 2023.
• A 3-year average of $1.1 billion and a median of $4.4 million in 2022 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2023: Inventory slumped 99.89% in 2022, then sank 84.49% in 2023.
• A 3-year view of Inventory shows it stood at $4.3 billion in 2021, then tumbled by 99.89% to $4.6 million in 2022, then slumped by 84.49% to $718742.3 in 2023.
• Business Quant data shows NBP's Inventory at $718742.3 in Q4 2023, $4.6 million in Q4 2022, and $4.1 million in Q2 2022.